×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
NEW OPPORTUNITIES FOR INFORMATION TECHNOLOGY IN PHARMACOVIGILANCE
Session Chair(s)
Maria Wishart
Medical Director, Global Patient Safety
Astrazeneca, United Kingdom
Adverse Drug Reaction (ADR) reporting via mobile devices
Learning Objective : Learn how mobility can facilitate ADR reporting. Learn how pharmaceutical companies can achieve live monitoring of ADRs related to their marketed products. Learn how pharmaceutical companies can achieve a closer interaction with patients regarding ADR reporting.
Speaker(s)
Adverse Drug Reaction (ADR) reporting via mobile devices
Maiken Hedegaard, MPharm
NNIT A/S, Denmark
Life Science IT Consultant
Social Media and Pharmacovigilance: Socialvigilance
Nabarun Dasgupta, PhD, MPH
Epidemico, Inc. , United States
Chief Science Officer
Online patient reporting of adverse events: a case study
Monica Elisabet Plöen, RPh
CTC Clinical Trail Consultant AB, Sweden
Safety Officer & Medical Coder
Have an account?